EGFR and melanoma: Importantly, the authors also found that the impacts of KIF22 depletion on the proliferation, apoptosis and glycolysis in A375 cells were partially attenuated after the treatment with EGF or Colivelin, suggesting that KIF22 silencing impeded the progression of melanoma by activating EGFR/STAT3 signaling.